Annovis Bio, Inc. (ANVS) Tops Q1 EPS by 6c

Annovis Bio, Inc. (NYSE: ANVS) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• JPMorgan Reiterates Overweight Rating on Dixon Technologies India Ltd (DIXON:IN)
• Kura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results
• Amazon.com (AMZN) Reiterated at Market Outperform by Citizens as Frontier Models Grow